About Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare Solutions, Inc. (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions. The Population Health segment includes the sale of health management and coordinated care solutions, which focus on hospitals, health systems, other care facilities and accountable care organizations (ACOs). The Netsmart segment provides software and technology solutions to the health and human services industry, which includes behavioral health, addiction treatment, intellectual and developmental disability services, child and family services and public health segments, as well as to post-acute home care organizations.

Receive MDRX News and Ratings via Email

Sign-up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter.

Miscellaneous

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) released its quarterly earnings results on Thursday, February, 15th. The software maker reported $0.18 earnings per share for the quarter, meeting the Zacks' consensus estimate of $0.18. The software maker had revenue of $547 million for the quarter, compared to analysts' expectations of $524.05 million. Allscripts Healthcare Solutions had a positive return on equity of 7.35% and a negative net margin of 10.88%. The business's revenue for the quarter was up 27.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.14 earnings per share. View Allscripts Healthcare Solutions' Earnings History.

When will Allscripts Healthcare Solutions make its next earnings announcement?

What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?

Allscripts Healthcare Solutions issued an update on its FY18 earnings guidance on Thursday, February, 15th. The company provided earnings per share (EPS) guidance of $0.72-0.82 for the period, compared to the Thomson Reuters consensus estimate of $0.79. The company issued revenue guidance of $2.15-2.25 billion, compared to the consensus revenue estimate of $2.15 billion.

Where is Allscripts Healthcare Solutions' stock going? Where will Allscripts Healthcare Solutions' stock price be in 2018?

2. According to Zacks Investment Research, "Allscripts has had a favorable run on the bourses over the last year, trading above the broader industry. The company’s solid growth in U.S. Core Solutions and Services holds promise at the moment. Allscripts Sunrise electronic health record (EHR) platform and Revenue Cycle Management Services are likely to drive the company’s top line in the quarters to come. Also, Allscripts has a leading market share in inpatient and ambulatory settings. Allscripts announced a definitive agreement to buy Practice Fusion for $100 million in cash. However, the company’s continued reliance on mergers and acquisition activities poses substantial integration risks. Intensifying competition is a major dampener. The company’s products have a long sales cycle which involves intensive decision-making at different managerial levels. Allscripts also expects a modest increase in operating expenses to support business growth over the long haul." (1/25/2018)

3. Maxim Group analysts commented, "MDRX announced the acquisition of Practice Fusion, a provider of cloud- based electronic health record (EHR) platforms, for $100M in cash. The acquisition is expected to close in 1Q18. We believe Practice Fusion was sold at 1.0x-2.0x revenue, implying a $50M- $100M revenue run rate. It is expected to be marginally accretive in 2018. We estimate that the company’s recently-acquired Enterprise Information Systems (EIS) business is operating at a roughly $400M-$450M revenue run rate, significantly above our original estimate of $300M. We believe attrition in the EIS business may be lower than originally projected." (1/9/2018)

How do I buy Allscripts Healthcare Solutions stock?

Shares of Allscripts Healthcare Solutions can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Allscripts Healthcare Solutions' stock price today?

One share of Allscripts Healthcare Solutions stock can currently be purchased for approximately $13.83.

How big of a company is Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions has a market capitalization of $2.33 billion and generates $1.81 billion in revenue each year. The software maker earns $2.88 million in net income (profit) each year or ($1.16) on an earnings per share basis. Allscripts Healthcare Solutions employs 7,500 workers across the globe.

MarketBeat's community ratings are surveys of what our community members think about Allscripts Healthcare Solutions and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.

MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.